Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer.
Journal: JCO precision oncology
Published: April 03, 2026
Response to DNA-damaging agents and PARP inhibitors in ATM mutated metastatic colorectal cancer: case series.
Journal: Chinese clinical oncology
Published: August 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study.
Journal: Cancer
Published: May 25, 2025
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and Recurrence.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 17, 2024
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
Journal: Cancer
Published: July 23, 2024
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas.
Journal: Journal of gastrointestinal oncology
Published: February 21, 2023
Changes in Prescribing Patterns in Stage III Colon Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: January 23, 2023
Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch Syndrome.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: January 14, 2023
Tucatinib: an investigational novel therapeutic agent for the treatment of HER-2 colorectal cancer.
Journal: Expert opinion on investigational drugs
Published: March 15, 2022
Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements.
Journal: Therapeutic advances in gastroenterology
Published: February 15, 2022
Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis.
Journal: Frontiers in oncology
Published: December 13, 2020
Last Updated: 09/26/2026